DHFR and neoplasm: Methotrexate (MTX) is an antimetabolite of folic acid used as an inhibitor of dihydrofolate reductase (DHFR) in the treatment of autoimmune and neoplastic diseases; it is unfortunately associated with adverse effects on multiple organs and this fact represents an important cause of drug withdrawal.